TUCSON, Ariz., Nov. 6, 2019 /PRNewswire/ -- On Nov 4, the United States

PLANO, Texas, Nov. 6, 2019 /PRNewswire/ -- Community Hospital Corporation (CHC) has announced new executives and promotions at the hospital and corporate level. Jim Kendrick, CHC President and CEO, said, "We are excited about new talent and rewarding staff who are dedicated to improving and sustaining the community hospitals we serve

RARITAN, N.J., Nov. 6, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today 46 company-sponsored and more than 30 investigator-led abstracts will be presented at the

WASHINGTON, Nov. 6, 2019 /PRNewswire/ -- Suicide is the tenth leading cause of death in the United States and the 15th leading cause of death in the District of Columbia. On Thursday, November 14, advocates from the

JERSEY CITY, N.J., Nov. 6, 2019 /PRNewswire/ -- Lawsuit Settlement News announced today that they are preparing for an influx of hernia mesh lawsuits, and have set up a helpline for plaintiffs seeking legal assistance.The two most popular brands of hernia mesh are Johnson & Johnson's Ethicon Physiomesh and Atrium Medical Corporation's C-QUR. Both devices

LOS ANGELES, Nov. 6, 2019 /PRNewswire/ -- Ritual, the direct-to-consumer multivitamin subscription company, has just announced their newest launch, Essential for Women 50+, a multivitamin designed for women post-menopause. 

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company in China focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "the Company of the Year,

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from the clinical program evaluating its lead candidate melflufen in multiple myeloma and Light Chain (AL) Amyloidosis have been selected for six poster presentations to be featured at the American Society of Hematology (ASH) 2019 Annual Meeting taking place

CAMBRIDGE, Mass., Nov. 6, 2019 /PRNewswire/ -- New clinical data from Sanofi's oncology and rare blood disorders portfolios and pipelines will be featured, including four oral presentations and 18 posters, at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition from December 7-10 in

BETHESDA, Md. and CINCINNATI, Nov. 6, 2019 /PRNewswire/ -- InFuse Holdings Inc. announced today a Series A investment led by BroadOak Capital Partners to build a network of high-quality, cost-effective infusion centers throughout Ohio and the Midwest.  The initial funding will be used to acquire